Literature DB >> 9331069

Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions.

A A Larson1, S Y Liao, E J Stanbridge, W K Cavenee, G M Hampton.   

Abstract

Carcinomas of the uterine cervix are thought to arise from preinvasive dysplastic lesions, termed cervical intraepithelial neoplasias (CIN), grades I-III. Patients may present clinically with two or more distinct lesions of differing histological severity; however, the genesis of these multifocal lesions is unknown. Despite infection with high-risk human papilloma virus subtypes, which is a major etiological factor in disease pathogenesis, only a small and unpredictable number of dysplastic lesions progress to invasive cancer. Several lines of evidence suggest that additional somatic events, such as tumor suppressor gene inactivation, are required for malignant transformation. In support of this, loss of heterozygosity (LOH) analyses of invasive cervical carcinomas have identified several chromosomal arms likely to harbor tumor suppressor genes, of which regions on 3p, 4p, 4q, and 11q have been validated extensively. To evaluate the potential role of tumor suppressor gene inactivation in dysplastic progression, loci distributed on these four chromosomal regions were assessed for LOH in 42 CIN lesions of varying histological grade obtained from 17 patients. Analysis of at least 16 microsatellite loci in each lesion revealed allelic losses involving one or more of these chromosomal regions in 0% of CIN I lesions; 25% of CIN II lesions; and 88% of CIN III lesions, with 41% of CIN III lesions exhibiting LOH for three or more chromosomal regions. In addition, where LOH was scored for the same locus at a particular chromosomal region in all of the multiple lesions from a single patient, the same allele was lost at each locus, without exception. Statistical analysis of these allele-specific losses strongly suggests that topologically distinct lesions are related and likely arise from a common precursor cell.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331069

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.

Authors:  E M Rakowicz-Szulczynska
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3.

Authors:  Y Cheng; N E Poulos; M L Lung; G Hampton; B Ou; M I Lerman; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers.

Authors:  D G Allen; A-M Hutchins; F Hammet; D J White; J P Scurry; S N Tabrizi; S M Garland; J E Armes
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

4.  Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer.

Authors:  D G Allen; D J White; A M Hutchins; J P Scurry; S N Tabrizi; S M Garland; J E Armes
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  Molecular progression to cervical precancer, epigenetic switch or sequential model?

Authors:  Belinda Nedjai; Caroline Reuter; Amar Ahmad; Rawinder Banwait; Rhian Warman; James Carton; Sabrina Boer; Jack Cuzick; Attila T Lorincz
Journal:  Int J Cancer       Date:  2018-07-03       Impact factor: 7.396

6.  Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan.

Authors:  Jinichi Sakamoto; Shoji Kamiura; Kaori Okayama; Mitsuaki Okodo; Takeo Shibata; Yasuhiro Osaka; Satoko Fujita; Emi Takata; Hiroaki Takagi; Masahiro Takakura; Toshiyuki Sasagawa
Journal:  Papillomavirus Res       Date:  2018-10-26

Review 7.  Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications.

Authors:  Roman Uzhachenko; Akiko Shimamoto; Sanika S Chirwa; Sergey V Ivanov; Alla V Ivanova; Anil Shanker
Journal:  Cancer Gene Ther       Date:  2022-02-18       Impact factor: 5.854

8.  Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene.

Authors:  Ratnesh Kumar Singh; Dipanjana Indra; Sraboni Mitra; Ranajit Kumar Mondal; Partha Sarathi Basu; Anup Roy; Susanta Roychowdhury; Chinmay Kumar Panda
Journal:  Hum Genet       Date:  2007-05-22       Impact factor: 5.881

9.  The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions.

Authors:  G Terry; L Ho; P Londesborough; P Cross; A Lopes; J Monaghan; J Cuzick
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

10.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.

Authors:  W Alazawi; M Pett; S Strauss; R Moseley; J Gray; M Stanley; N Coleman
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.